Cargando…
Revisiting the SAR of the Antischistosomal Aryl Hydantoin (Ro 13-3978)
[Image: see text] The aryl hydantoin 1 (Ro 13-3978) was identified in the early 1980s as a promising antischistosomal lead compound. However, this series of aryl hydantoins produced antiandrogenic side effects in the host, a not unexpected outcome given their close structural similarity to the antia...
Autores principales: | Wang, Chunkai, Zhao, Qingjie, Vargas, Mireille, Jones, Jeremy O., White, Karen L., Shackleford, David M., Chen, Gong, Saunders, Jessica, Ng, Alice C. F., Chiu, Francis C. K., Dong, Yuxiang, Charman, Susan A., Keiser, Jennifer, Vennerstrom, Jonathan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5150661/ https://www.ncbi.nlm.nih.gov/pubmed/27933964 http://dx.doi.org/10.1021/acs.jmedchem.6b01410 |
Ejemplares similares
-
In vitro and in vivo antischistosomal activity of ferroquine derivatives
por: Keiser, Jennifer, et al.
Publicado: (2014) -
Orally Active Antischistosomal Early Leads Identified from the Open Access Malaria Box
por: Ingram-Sieber, Katrin, et al.
Publicado: (2014) -
Cu-catalyzed N-3-Arylation
of Hydantoins Using Diaryliodonium Salts
por: Neerbye Berntsen, Linn, et al.
Publicado: (2020) -
Development of Praziquantel sulphonamide derivatives as antischistosomal drugs
por: Angeli, Andrea, et al.
Publicado: (2022) -
Mefloquine—An Aminoalcohol with Promising Antischistosomal Properties in Mice
por: Keiser, Jennifer, et al.
Publicado: (2009)